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Update
Stem Cells, Embryos, and Ethics: 
Is There a Way Forward?
LOMA LINDA UNIVERSITY CENTER FOR CHRISTIAN BIOETHICS
We are at a crucial moment in the process of scientific discovery. The dramatic advances in molecular biology throughout the
20th century have culminated in the sequencing of the human genome and increasing knowledge of cell physiology and cytol-
ogy. These studies were accomplished by breaking down organic systems into their component parts. Now, however, as we move
on from genomics and proteomics to discoveries in developmental biology, we have returned to the study of living beings. When
applied to human biology, this inquiry reopens the most fundamental questions concerning the relationship between the mate-
rial form and the moral meaning of developing life.
The current conflict over embryonic stem (ES) cell research is just the first in a series of difficult controversies that will
require us to define with clarity and precision the moral boundaries we seek to defend. Human-animal chimeras, parthenogen-
esis, projects involving the laboratory production of organs—and a wide range of other emerging technologies will continue to
challenge our definitions of human life. These are not questions for science alone, but for the full breadth of human wisdom
and experience. 
The scientific arguments for going forward with this research are strong. The convergence of these advancing technologies
is delivering unprecedented powers for research into the most basic questions in early human development. Beyond the obvi-
ous benefit of understanding the biological factors behind the estimated 150,000 births with serious congenital defects per year,
it is becoming increasingly evident that certain pathologies that are only manifest later in life are influenced or have their ori-
gins in early development. Furthermore, fundamental developmental processes (including the formation and functioning of
stem cells), and their disordered dynamics, seem to be at work in a range of adult pathologies including some forms of cancer.
Yet, from the moral and social perspective there are serious concerns.
It is important to acknowledge the many scientific projects for which human embryos could be used. Beyond their destruc-
tion for the procurement of embryonic cells, some individuals fear the industrial scale production of living human embryos for
a wide range of research in natural development, toxicology, and drug testing. 
Lord Alton, a member of the House of Lords in the United Kingdom, told me that they estimate more than 100,000 human
embryos have already been used in scientific experimentation in Britain.
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conception, a new life is initiated with a distinct genetic
endowment that organizes and guides the growth of a
unique and unrepeatable human being. 
The gametes (the sperm and egg), although alive as
cells, are not living beings: they are instrumental organic
agents of the parents. The joining of the gametes brings
into existence an entirely different kind of entity, a living
human organism. With regard to fundamental biological
meaning (and moral significance), the act of fertilization is
a leap from zero to everything.
In both structure and function, the zygote (the one-cell
embryo) and subsequent embryonic stages differ from all
other cells or tissues of the body; they contain within them-
selves the organizing principle for the full development of a
human being. The very word organism implies organiza-
tion—an overarching principle that binds the parts and
processes of life into a harmonious whole. As a living being,
an organism is an integrated, self-
developing, and self-maintaining
unity under the governance of an
immanent plan.
For an embryonic organism,
this implies an inherent potency,
an engaged and effective poten-
tial with a drive in the direction
of the mature form. By its very
nature, an embryo is a develop-
ing being. Its wholeness is
defined by both its manifest
expression and its latent poten-
tial; it is the phase of human life
in which the “whole” (as the uni-
fied organismal principle of growth) precedes and produces
its organic parts. The philosopher Robert Joyce explains:
“Living beings come into existence all at once and then grad-
ually unfold to themselves and to the world what they already,
but only incipiently, are.”1 To be a human organism is to be a
whole living member of the species Homo sapiens, with a
human present and a human future evident in the intrinsic
potential for the manifestation of the species’ typical form.
Joyce continues: “No living being can become anything other
than what it already essentially is.” 
It is this implicit whole, with its inherent potency, that
endows the embryo with continuity of human identity from the
moment of conception and therefore, from this perspective, invi-
olable moral status. To interfere in its development is to trans-
gress upon a life in process. The principle of this analysis applies
to any entity that has the same potency as a human embryo pro-
duced by natural fertilization, regardless of whether it is the prod-
uct of in vitro fertilization (IVF), cloning, or other processes.
Beyond that, there is concern about the commodification
and commercialization of eggs and embryos, and worry about
the implications of ongoing research to create an artificial
endometrium (a kind of artificial womb) that would allow the
extracorporeal gestation of cloned embryos to later stages for
the production of more advanced cells, tissues, and organs. 
Furthermore, from a social perspective, do we really want
to have red state medicine/blue state medicine? The emerg-
ing patchwork of policies on the state level threatens to cre-
ate a situation in which a large percentage of patients will
enter the hospital with moral qualms about the foundations
on which their treatments have been developed. What was
traditionally the sanctuary of compassionate care at the most
vulnerable and sensitive moments of human life is becoming
an arena of controversy and conflict. 
Clearly, both sides of this difficult debate are defending
important human goods—and
both of these goods are impor-
tant for all of us. A purely politi-
cal solution will leave our
country bitterly divided, eroding
the social support and sense of
noble purpose that is essential
for the public funding of bio-
medical science. While there are
currently no federally legislated
constraints on the use of private
funds for this research, there is a
consensus opinion in the scien-
tific community that without
NIH support for newly created
embryonic stem cell lines, progress in this important realm of
research will be severely constrained. The current conflict in
the political arena is damaging to science, to religion, and to
our larger sense of national unity. The way this debate is pro-
ceeding is, in my opinion, completely contrary to the positive
pluralism that is the strength of our democracy.
What is needed is to draw back from the polarized posi-
tions of political rhetoric and to respectfully reflect on the
meaning of the moment we are in. 
In the spirit of such a dialogue, and in the hope that it
might lead us toward a resolution of our difficult national
impasse over embryonic stem cell research, I offer the per-
spective that follows.
MORAL MEANING OF EMERGING LIFE
Any evaluation of the moral significance of human life
must take into account the full procession of continuity and
change that is essential for its development. With the act of
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3ACCRUED MORAL STATUS
The major alternative to the view that an embryo has an
inherent moral status is the assertion that moral status is an
accrued or accumulated quality related to some dimension
of morphology or function. 
The three arguments currently given in support of a 14 day
limit on embryo research—lack of differentiation, lack of indi-
viduation, and pre-implantation status—are based on a kind
of “received tradition” that dates back to the 1986 Warnock
Commission in the United Kingdom. But this commission
explicitly acknowledged the continuous nature of embryonic
development, stating: “There is no particular part of the
developmental process that is more important than any
other.” In a recent memoir, Mary Warnock discussed the util-
itarian grounding of her commission’s analysis, acknowledg-
ing that her committee’s task was “to recommend a policy
which might allow the sort of medical and scientific progress
which was in the public interest.”2 Indeed, recent advances in
embryology do not support this commission’s conclusions. 
DIFFERENTIATION
The argument on differentiation is based on the idea
that before gastrulation (which begins around the 12th to
14th day with the formation of the primitive streak (Fig. 1),
the embryo is an inchoate clump of cells with no actuated
drive in the direction of distinct development. 
It is argued that the undifferentiated quality of the blas-
tocyst (the four-five day embryo) justifies its disaggregation
for the procurement of stem cells, while the evident orga-
nization at gastrulation reveals an organismal integrity that
endows inviolable moral status to all subsequent stages of
embryological development.
Scientific evidence, however, supports the opposing
argument—that from conception there is an unbroken con-
tinuity in the differentiation and organization of the emerg-
ing individual life. 
“Stem Cells, Embryos, and Ethics” continued… • The anterior-posterior axis appears to be already estab-
lished within the zygote (the one-cell stage). 
• The earliest embryonic cell divisions (at least at by the
four-cell stage) exhibit differential gene expression.
• The unequal cytoplasmic concentrations of cell con-
stituents in the early embryo suggest distinct cellular fates. 
All this implies that the changes at gastrulation do not rep-
resent a discontinuity of ontological significance (a change in
the nature of being), but merely the visibly evident culmina-
tion of more subtle developmental processes at the cellular
level that are driving in the direction of organismal maturity.3
These new scientific perspectives were documented in a July
2002 article in Nature: “The mammalian body plan starts
being laid down from the moment of conception…a surpris-
ing shift in embryological thinking.” 
TWINNING
Another argument for accrued moral status is that, as long
as an embryo is capable of giving rise to a twin, it cannot be
considered to have the moral standing of an individual. 
Yet monozygotic twinning, which occurs in just one in 240
births, does not appear to be either an intrinsic drive or a ran-
dom process within embryogenesis. Rather, it results from a
disruption of normal development by a mechanical or bio-
chemical disturbance of fragile cell relationships. This pro-
vokes a compensatory repair, but with the restitution of
integrity within two distinct trajectories of embryological
development. 
In considering the implications of twinning for individua-
tion, one might better ask the question from the opposite per-
spective. What keeps each of the cells of the early embryo
from becoming a full embryo? Clearly, crucial relational
dynamics of position and intercellular communication are
already at work, establishing the unified pattern of the emerg-
ing individual. 
From this perspective, twinning is not evidence of the
absence of an individual, but of an extraordinary power of
compensatory repair that reflects more fully the potency of
the individual drive to fullness of form even in the earliest
stages of embryonic human life.
IMPLANTATION
Some have argued that the implantation of the embryo
within the uterine lining of the mother constitutes a moment
of altered moral status. 
Fertilization occurs in the fallopian tubes. The embryo
floats down into the uterus and begins to implant in the uter-
ine wall around the sixth–seventh day. All along this journey,
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Fig. 1
With respect to fundamental moral status therefore, the
human being is an embodied being whose intrinsic dignity is
inseparable from its full procession of life and always present
in its varied stages of emergence.
This conclusion is consistent with 2,500 years of medical
science—as recently as 1948, the Physician’s Oath in the
Declaration of Geneva, echoing the enduring traditions of
Hippocratic medicine, proclaimed: “I will maintain the utmost
respect for human life from the time of conception. …”
As we descend into an instrumental use of human life,
we destroy the very reason for which we were undertaking
our new therapies; we degrade the humanity we were 
trying to heal.
IN VITRO FERTILIZATION EMBRYOS
This brings us to the dilemma of the moral status of an
estimated one million embryos left over from in vitro fertil-
ization (IVF). Created to give life, they are now suspended
in time and space and the uncertainty of a conflicted fate.
In this canister (Figure 2) in the Assisted Reproduction
Technologies clinic at
Stanford are 300 embryos.
The water in their cells has
been replaced with glycerol,
and they are immersed in liq-
uid nitrogen at a temperature
of minus 200 degrees Celsius.
(I joke with my friend, the
director of the lab, that this
must be the densest popula-
tion in human history.)
But the future of these
embryos is a poignant prob-
lem. In some cases, such embryos have been implanted as
long as 12 and a half years after freezing, including one born
seven and a half years after its twin. In other cases, there
have been custody battles over the frozen embryos after
divorce, and even a dispute over inheritance when a wealthy
couple died in an airplane crash and left several embryonic
hiers with numerous couples stepping forward and offering
to adopt them. But most of these one million frozen
embryos do not have such privileged prospects. They are
castoffs, destined to be discarded or disaggregated in the
service of medical science. 
And this is a warning to us of how even the best inten-
tions of our science, unconstrained by the forethought of
moral consideration, slip slowly along the gradient of utility.
Each of these embryos, once the precious promise of a
happy baby, is now relegated to the category of mere mat-
ter, raw material in a larger program of scientific progress. 
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the diffusion of essential nutrients and growth factors sustains
the life and nourishes the growth of the developing embryo.
Implantation and the development of the placenta simply
extend this relationship between mother and embryo, with an
internal circulation as the embryo gets too large to be nour-
ished by direct diffusion.
Implantation, then, must be viewed as just another step
in a continuum of ongoing intimate dependence, all occur-
ring along the trajectory of natural development that begins
with conception and continues into infancy. This continu-
ity implies no meaningful moral marker at implantation.
FUNCTION
Most other arguments relate in some way to the onset of a
specific function or capacity. Arguments for a change in moral
status based on function are at once the most difficult to
refute and to defend. 
The first and most obvious problem is that the essential
functions (and even their minimal criteria and age of onset) are
diverse and arbitrarily assigned. Generally they relate to the
onset of sentience—awareness of pain, or some apparently
unique human cognitive capability such as consciousness. 
This approach raises a number of disturbing ethical
questions. 
• If human moral worth is based on actual manifest func-
tions, then does more of that function give an individual
life a higher moral value? 
• And what are we to make of the parallel functional capac-
ities in animals that we routinely sacrifice for food and
medical research? 
• Furthermore, what becomes of human moral status with
the degeneration or disappearance of such functions?
While we might argue that our relational obligations
change along with changes in function, such as occur
with senile dementia, we would not sanction a utilitarian
calculus and the purely instrumental use of such persons
no matter how promising the medical benefits might be.
More fundamentally, from a scientific perspective, there is
no meaningful moment when one can definitively designate
the biological origins of a human characteristic such as con-
sciousness. The human being is an inseparable psycho-
physical unity. Our thinking is in and through our bodily
being, and thus the roots of our consciousness reach deep into
our development. The earliest stages of human development
serve as the indispensable and enduring foundations for the
powers of freedom and self-awareness that reach their fullest
expression in the adult form. 
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However much we may agree or disagree with the
process that put them there, we should acknowledge that
this is a difficult dilemma. Produced with a healing purpose,
the good intentions of overcoming the sorrow of infertility,
they are now abandoned to a project of a completely differ-
ent character. Some say that if there is a moral problem, it is
upstream in the process that put them there, and that now,
since they are destined to die, what further harm can be
done? As a pragmatic people, many Americans feel the
weight of this argument. And, if we fail to develop a morally
acceptable alternative source of embryonic stem cells, I sus-
pect that is where our national policy may settle.
Yet, even if use of these
embryos becomes accepted pol-
icy and practice, we should be
aware of something more compli-
cated that is below the surface:
There has been a slow but steady
shift in our underlying attitude
toward human life. As we gain
the powers of comprehension
and control over our most basic
biology, there is a transforma-
tion—not just in our physical
being, but in our whole sense of
who we are, and of our place and
purpose within the natural order.
As we take increasing instru-
mental control over natural life processes, our attitude
changes and we lose the sense of cautionary reverence and
respect. With each step, however benevolent the initial
intention, there is a moral danger, a fracturing of matter and
meaning that breaks the coherence and natural connections
of life. With each step, the original radiance and vitality of
the cosmos, its order, beauty, and coherent moral meaning
are obscured by the conviction that all of living nature is
mere matter and information to be reshuffled and reas-
signed for the projects of the human will.
This instrumental use of life reaches its most ominous
extension as we relegate the human embryo to the status of
a resource, as raw material in the service of our project in the
mastery over nature. Such an instrumental use of early
human life opens a doorway down a long corridor indeed. 
For one thing, many of these embryos are not at the develop-
mental state for harvesting embryonic stem cells and would have
to undergo further laboratory culture to the blastocyst stage. Will
we not want to use some for experiments to perfect the culture
medium? And while we are at it, there are many other studies
that could be done on early embryos to help perfect IVF. 
Thirty years ago, when IVF first came on the scene, there
was a difficult debate in Congress over support of research
that involves the destruction of human life. This debate cul-
minated in 1996 with the passage of the Dickey Amendment,
which forbids federal funding for projects that endanger or
destroy human embryos. As with abortion, IVF, involving the
creation and implantation or disposal of embryos, would be a
matter of personal choice done with private funds.
Will we now retreat and override this decision—or is only
embryonic stem cell research urgent enough to justify an
exception to this long-standing federal policy? Furthermore,
even if we endorse this course of action, the 14-day limit on
the use of human embryos will not hold since it does not
stand up to logical argument. As
discussed above, the designa-
tion of 14 days as the moral
boundary for embryo experi-
mentation is in the category of
a “received tradition,” almost a
superstition in the sense that it
is a belief in a change of state
without a discernible cause. As
a moral marker, 14 days makes
no sense; it is arbitrarily set and
therefore vulnerable to trans-
gression through the persuasive
promise of further scientific
benefit.
BEYOND CELLS
And it is becoming increasingly apparent that the promise
of stem cells lies beyond simple cell cultures and cell replace-
ment. The technological goal is to produce more advanced
cell types and even tissues, organs, and possibly limb primor-
dia. Producing such complex tissues and organs may require
the intricate cell interactions and microenvironments now
available only through natural gestation.
During embryogenesis, differentiation and organ formation
unfold within the fragile spatio-temporal induction of a highly
specific sequence of cell signaling—different signals coming
from different sides and in a perfect synchrony of process. 
Consider the formation of the human hand. It begins as a
small bud induced off the trunk of the embryo; then through
an extraordinary orchestration of cell interactions, it progres-
sively unfolds toward its functional form. But once initiated
(after about the fifth or sixth week of embryogenesis,
Figure 3), the limb bud can actually be severed from the
embryo and, given the right environment, will continue its
momentum of development as an independent unit.
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I have seen just such a hand in the bottom of a test tube.
The tiny limb bud, snipped from the fetal remains of a five
week old aborted fetus, was implanted into the abdominal
cavity of an SCID mouse (a special kind of mouse that won’t
reject the tissue), and grown till it was about one-quarter inch
wide. I looked down on that little hand and I thought to
myself—this is fantastic; one day we may grow limbs for peo-
ple with congenital malformations, or injuries and amputa-
tions. But at the same time I thought—this was going to be
someone’s little hand, that tender little newborn hand that
lays across his mother’s breast while nursing. 
But if we might one day grow human limbs, we might
even more easily grow other organs—kidneys, livers, and
hearts. Scientists in Israel have already established that
human kidney primordia taken from seven-to-eight-week-
old aborted fetuses can be successfully grown in mice—a
feat proclaimed as “a breakthrough that might one day help
save thousands of patients waiting for transplants.” (There
are 50,000 people in the United States alone on dialysis,
waiting for kidney transplants—an estimated 17 deaths a
day are due to the inadequate organ supply.) Furthermore,
several years ago, it was announced that a scientist in China
successfully sustained in vitro a human heart severed from
its source in a seven-week-old aborted fetus.
The benefits of implanting embryos in order to employ the
developmental dynamics of natural embryogenesis for the pro-
duction of limb and organ primordia seem self-evident.
The implantation of cloned embryos (either into the nat-
ural womb or possibly an artificial endometrium) for the pro-
duction of patient-specific tissue types to bypass problems of
immune rejection would further extend the logic of the
instrumental use of developing life.
The public pressure that has already been brought to bear
on the politics of stem cells and cloning by patient advocacy
groups has provoked such a sense of promise that it may pro-
pel the argument for allowing such gestation of cloned human
embryos.
Over the past four years, I have talked with hundreds of
people, including many scientists, who say that they would
find such a practice (that is, the implantation of a cloned
embryo) acceptable to save the life of a dying child. 
Different people have different limits to the duration of
gestation they find morally acceptable, but in light of the
current sanction of abortion up to and beyond the end of
the second trimester, it is difficult to argue that the creation,
gestation, and sacrifice of a clone to save an existing life is
a large leap in the logic of justification. The argument is
made that if abortion is legal—that is, if a developing life
can be terminated with no reason given—then why not for
a good reason? One must admit there is a certain perverse
logic to this argument.
WHITE PAPER
In light of the arguments given above that human moral
worth is based on a continuity of embodied form from fertil-
ization to natural death, it would seem that we are at an irre-
solvable impasse. If embryonic stem cells can be obtained
only by the destruction of human embryos, this may, in fact,
be the case. But last May, a white paper by the President’s
Council on Bioethics suggested otherwise. This report
describes four proposals put forward as possible means of
obtaining embryonic stem cells without the creation and
destruction of human embryos.
As the author of one of the proposals, altered nuclear trans-
fer, I would like to draw on this to discuss the scientific
advances and moral reasoning that may lead us to a techno-
logical solution to our national conflict.
ALTERED NUCLEAR TRANSFER
As described above, natural conception signals the activa-
tion of the organizing principle for the self-development and
self-maintenance of the full human organism. In the language
of stem-cell biology, this capability is termed “totipotency,”
the capacity to form the complete organism. A naturally fer-
tilized egg, the one cell embryo, is totipotent. 
In contrast, the term “pluripotency” designates the
capacity to produce all the cell types of the human body,
but not the coherent and integrated unity of a living being.
Embryonic stem cells are merely pluripotent. This is a dif-
ference between the material parts and the living whole. 
Altered nuclear transfer (ANT) would draw on the basic
technique of SCNT (popularly known as “therapeutic
cloning”) but with an alteration such that pluripotent stem
“Stem Cells, Embryos, and Ethics” continued…
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cells are produced without the creation and destruction of
totipotent human embryos.
In standard nuclear transfer, the cell nucleus is removed
from an adult body cell and transferred into an egg cell that
first has its own nucleus removed. The egg then has a full set
of DNA and, after it is electrically stimulated, starts to divide
like a naturally fertilized egg. This is how Dolly, the sheep,
was produced.
Altered nuclear transfer uses the technology of nuclear
transfer but with a preemptive alteration that assures that no
embryo is created. The adult body cell nucleus or the enu-
cleated egg’s contents (or both) are first altered before the
adult body cell nucleus is transferred into the egg. The
alterations cause the adult body cell DNA to function in
such a way that no embryo is generated, but pluripotent
stem cells are produced.
There is natural precedent for such a project. In normal
conception, fertilization signals the activation of the organizing
principle for the self-development of the full human organism.
But without all of the essential elements—the necessary
complement of chromosomes, proper epigenetic configura-
tion, and the cytoplasmic factors for gene expression—there
can be no living whole, no organism, and no human embryo.
Recent scientific evidence suggests incomplete combina-
tions of the necessary elements—“failures of fertilization”—
are the fate of many, perhaps most, of early natural initiations
in reproduction. 
FAILURES OF FERTILIZATION
It is important to realize that many of these naturally
occurring failures of fertilization may still proceed along
partial trajectories of organic growth without being actual
organisms. For example, certain grossly abnormal kary-
otypes (including haploid genomes, with only half the nat-
ural number of chromosomes) will form blastocyst-like
structures but will not implant.
Even an egg without a nucleus, when artificially activated,
has the developmental power to divide to the eight-cell stage,
yet clearly is not an embryo—or an organism at all. The
mRNA for the protein synthesis that drives these early cell
divisions is generated during the maturation of the egg and
then activated after fertilization. Like a spinning top, the cells
contain a certain biological momentum that propels a partial
trajectory of development; but unlike a normal embryo, they
are unable to bootstrap themselves into becoming an inte-
grated and self-regulating organism. 
Some of these aberrant products of fertilization that lack
the qualities and characteristics of an organism appear to be
capable of generating ES cells or their functional equivalent.
Mature teratomas are benign tumors that generate all three
primary embryonic cell types, as well as more advanced cells
and tissues, including partial limb and organ primordia—and
sometimes hair, fingernails, and even fully formed teeth.
(The white opacities in this x-ray are adult-size molars,
Figure 5.) Yet these chaotic, disorganized, and nonfunctional
masses are like a bag of jumbled puzzle parts, lacking
entirely the structural and dynamic character of organisms.
Neither medical science nor the major religious traditions
have ever consid-
ered these growths
to be “moral
beings” worthy of
protection; yet they
produce embryonic
stem cells.
These benign
ovarian tumors
appear to be
derived by spontaneous development of activated eggs.
The disorganized character of teratomas appears to arise,
not from changes in the DNA sequence, but from genetic
imprinting—an epigenetic modification that affects the
pattern of gene expression (keeping some genes turned off
and others on). In natural reproduction, the sperm and egg
have different but complementary patterns of imprinting,
allowing a coordinated control of embryological develop-
ment. When an egg is activated without a sperm, the tro-
phectoderm (the outer layer in a natural embryo—sometimes
called the trophoblast) and its lineages fail to develop properly.
In the absence of the complementary genetic contribution of
Please turn to page 8
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the male, the activated egg is simply inadequately constituted
to direct the integrated development characteristic of human
embryogenesis. 
SYSTEMS BIOLOGY
This example points to another new dimension of our
advancing knowledge. Through systems biology, we are
beginning to recognize how even a small change of one gene
can affect the entire balance of an enormous network of bio-
chemical processes necessary to initiate and sustain the exis-
tence of a living being.
Systems biology offers us the view of an organism as a
dynamic whole, an interactive web of interdependent
processes that express emergent properties not apparent in
the biochemical parts. Within this dynamic self-sustaining
system is the very principle of life, the organizing informa-
tion and coordinated coherence of a living being. With the
full complement of coordinated parts, an organismal system
subsumes and sustains the parts; it exerts a downward cau-
sation that binds and balances the parts into a patterned pro-
gram of integrated growth and development. Partial organic
subsystems (cells, tissues, and organs) that are components
of this larger whole, if separated or separately produced, may
temporarily proceed forward in development. But without
the coherent coordination and robust self-regulation of the
full organism, they will ultimately become merely disorga-
nized cellular growth. 
ANT proposes that small, but precisely selected alter-
ations will allow the harnessing of partial developmental tra-
jectories apart from their full natural context in order to
produce ES cells.
CDX2 
Altered nuclear transfer is a broad concept with a range of
possible approaches; there may be many ways this technique
can be used to accomplish the same end.
One variation involves the deletion or silencing of a gene
essential at the most primary level of coordinated organiza-
tion. As described in a January 2006 paper in the journal
Nature, stem-cell biologist Rudolf Jaenisch has established
the scientific feasibility of this approach in a series of dramatic
mouse model experiments in which he procured fully func-
tional embryonic stem cells from a laboratory construct that is
radically different in developmental potential than a normal
embryo.4
Using the technique of RNA interference, he was able to
reversibly silence the gene Cdx2 in the donor nucleus
before nuclear transfer to the enucleated egg. And a study
just two months ago in the journal Science suggests that it
may be possible to achieve the goals of ANT through the
preemptive silencing of Cdx2 in the egg even before the act
of nuclear transfer, thereby producing the biological (and
moral) equivalent of an inner cell mass tissue culture. This
article showed that in mice, mRNA for Cdx2 is present in
the egg and asymmetrically distributed in the first cell divi-
sion after fertilization. This asymmetric distribution of Cdx2
directs the cells at the two-cell stage to form two distinct cell
lineages. One of the cells at the two-cell stage goes on to
become the trophectoderm and forms the outer layer of the
embryo (and later the extra-embryonic membranes, includ-
ing the placenta). The other cell forms the “inner cell
mass,” which is the source of embryonic stem cells. By
selective silencing of Cdx2, the authors were able to pro-
duce an unorganized mass composed exclusively of cells
with the character of inner cell mass. 
This is the organic equivalent of a model airplane kit with-
out the glue; you have parts but no capacity to form a coherent
whole. The gene Cdx2 has been shown in mouse models to be
essential for the early integration of organismal function. In the
absence of expression of this gene, as with a teratoma, the tro-
phectoderm fails to grow and there is only partial and unorga-
nized cellular process. Lacking one of the two essential cell
types, it is the equivalent of trying to sing a duet with only one
voice. The coordinated interactions that are essential for
embryonic development are simply not possible. Nonetheless,
an inner cell mass is produced from which functional embry-
onic stem cells can be extracted. 
It is important to recognize that the improper develop-
ment of the trophectoderm is not reasonably considered a
defect within a part, but rather a failure in the formation of
the whole. An early embryo does not have parts in quite the
same sense as an adult organism, or even as a later-stage
embryo just a few days or weeks later. Natural embryogen-
esis is, by definition, the period during which the whole, as
the unified principle of growth, produces the parts. The
differentiation of parts during early embryogenesis lays
down the fundamental axes, body plan, and pattern of inte-
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grated organogenesis. An embryo does not have a central
integrating part like the brain; rather, the essential being is
the whole being. At this stage, a critical “deficiency” is
more rightly considered an “insufficiency”—not a defect in
a being, but an inadequacy at such a fundamental level that
it precludes the coordinated coherence and developmental
potential that are the defining characteristics of an embry-
onic organism. In testimony to a U.S. Senate subcommittee
on stem-cell research, Dr. Jaenisch stated: “Because the
ANT product lacks essential properties of the fertilized
embryo, it is not justified to call it an ‘embryo.’”5
Many scientists, moral philosophers, and religious
authorities (including some of the most conservative evan-
gelical and Catholic leaders) have expressed strong encour-
agement for further exploration of this project. Of course,
additional animal studies including some with non-human
primates, must precede any translation of these findings
into practice with human cells. 
ADVANTAGES OF ANT
ANT, in its many variations, could provide a uniquely flex-
ible tool and has many positive advantages that would help
advance stem cell research.
• Unlike the use of embryos from IVF clinics, ANT would
produce an unlimited range of genetic types for the
study of disease, drug testing, and possibly generation of
therapeutically useful cells.
• By allowing controlled and reproducible experiments,
ANT would provide a valuable research tool for a wide
range of studies of gene expression, imprinting, and
intercellular communication. Furthermore, the basic
research essential to establishing the ANT technique
would advance our understanding of developmental
biology and might serve as a bridge to transcendent
technologies, such as direct reprogramming of adult
cells.
• Moreover, as a direct laboratory technique, ANT would
unburden embryonic stem-cell research from the addi-
tional ethical concerns of the “leftover” IVF embryos,
including the attendant clinical and legal complexities in
this realm of great personal and social sensitivity. 
The one remaining link with IV—the procurement of
oocytes—is a subject of intense scientific research, and there
appear to be several prospects for obtaining eggs without the
morally dubious and expensive hormonally induced super-
ovulation of female patients. These include the use of eggs
left over from IVF, the laboratory maturation of eggs cultured
from ovaries obtained after surgical removal or from cadavers,
and possibly the direct production of eggs from embryonic
stem cells (a feat already accomplished with mouse cells).
CONCLUSION
We are at a crucial moment in the progress of science and
civilization. Advances in biology have delivered new powers
with extraordinary potential for positive application in both
basic research and clinical medicine. Yet, at the same time,
these new possibilities challenge the most fundamental moral
principles on which our society is based. Clearly, both sides of
this difficult debate over embryonic stem cell research are
defending something important to all of us. Without a resolu-
tion that sustains social consensus, there will be a series of
continuing conflicts as our science challenges us with further
dilemmas at the boundaries of human life. 
English author G.K. Chesterton had a metaphor that may
inform our current situation. Little boys are playing soccer on
an island, but at the very edges of the field, cliffs go down hun-
dreds of feet to the waves crashing against the rocky shore. The
boys are playing, but only in the middle 20 yards—no one
wants to do a corner kick. Then someone comes and builds a
sturdy fence right at the edges of the field: now they can play
within the full field without fear of falling off the cliff. 
Our current conflict is like this: Science is stalled across a
broad front. If we can define with clarity and precision the
moral boundaries we are trying to defend, we might open a
wider arena of legitimate study without fear of the grave dan-
gers posed by breach of the basic moral principles that sustain
Please turn to page 10
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of St. John of the Cross: “In the evening of life, we will be
judged by love.”
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our civilization. In provoking just such reflection and clarity of
definition, the proposal for altered nuclear transfer sets the
foundation for a positive future of scientific advance. 
Yet, some will say, “How can such a tiny clump of cells hold
such significance?”
Three hundred years ago French philosopher-
mathematician Blaise Pascal noted that human existence is
located between infinities—between the infinitely large and
the infinitely small. He went on to say, “By size, the universe
surrounds and swallows me up like a dot: by thought I encom-
pass the universe.” 
But what kind of thought could encompass the universe?
That thought must be a moral thought—that thought 
must be love. 
C.S. Lewis once said that we should answer all of our prob-
lems with more love, not less love—that precious love that
nourished and sustained each one of us in the early dawn of our
unfolding form. 
Now, as we prepare to enter the future with the new powers
of our scientific understanding, we should remember the words
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I am so excited to be able to offer our readers the article here
from William Hurlbut, MD. As a researcher, a member of the
President’s Council on Bioethics, and a well-informed theologian,
he offers here an eloquent position on the moral status of the
human embryo. In addition, he offers a vision for a way forward
with research that would be morally acceptable to all parties in our
national debate over stem-cell research. He advocates for a partic-
ular method of generating stem cells he calls altered nuclear trans-
fer over against somatic cell nuclear transfer, commonly called
cloning. To be clear, Dr. Hurlbut is in favor of stem-cell research,
but in the effort to protect human life, he wants to use cells gen-
erated from the altered nuclear transfer method he describes here.
I very much enjoyed his visit to our campus and applaud him in
his efforts to find consensus in the national context. 
His position on the moral status of the human embryo is
clear. After conception, the resultant human life is inviolable.
As you know, our Center for Christian Bioethics routinely
publishes articles with which we agree and disagree. In fact,
among our Seventh-day Adventist readers, many will agree
with Dr. Hurlbut and many will disagree. Implicit in the
Seventh-day Adventist statement, “Guidelines on Abortion,”
is a more developmental view of the embryo. Attached to this
document is a 12 point statement titled “Principles for a
Christian View of Life” (available at
<www.adventist.org/beliefs/guidelines/main_guide1.html>).
This more developmental view, as some call it, does not seek
Director, Center for Christian Bioethics
Loma Linda University
to denigrate the moral status of the embryo in any way, shape,
or form. It does, however, seek to recognize that, in excep-
tional and tragic circumstances, there may be justifiable rea-
sons to override the moral status of the embryo. What would
those circumstances be? In the statement, rape and incest are
mentioned as justifiable reasons. 
The Seventh-day Adventist Church does not yet have a for-
mal statement on stem-cell research; it is currently working on
this issue. A few indicators point in the direction of a position
in favor of support for some types of stem-cell research. First,
the implicit developmental view thus far taken by the Church
leans away from the view of the embryo as inviolable. Second,
the direction our healing ministries have taken in the past has
blended cutting-edge medical science and technology with our
spiritual concern for persons. Third, coupled with our tendency
to be on the cutting edge, our intense desire to extend the heal-
ing ministry of Jesus inclines us toward the very promising
therapies that most believe will come from stem-cell research. 
Ours is not a boring time, and those of us here at Loma
Linda University and the Center for Christian Bioethics feel
privileged to be involved.
William B. Hurlbut, MD, is a physician
and consulting professor at the Stanford
University Medical Center Neuroscience
Institute. Dr. Hurlbut has served on the
President’s Council on Bioethics since 2002.
He is a member of the chemical and biologi-
cal warfare working group at the Center for
International Security and Cooperation.
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The Riverside location drew a large crowd to the 15th annual Contributor’s Convocation. It was a wonderful Sabbath day filled
with moments of transformation and enlightenment. Stephen King, senior vice president of mission and ministry, Centura
Health; and Ruthita Fike, executive vice president for hospital affairs, Loma Linda University Adventist Health Sciences
Center, shared some of the challenges of offering health care as a ministry in a world that is entirely business-oriented. 
Two of our students in the master of arts program in biomedical and clinical ethics—George Dzimiri and Whitny Braun—
shared a bit of their research, as did the newest members of the School of Religion: Carla Gober, returning to Loma Linda
University from Emory University, where she is finishing up her PhD; Andy Lampkin, who comes to us from Oakwood College;
and Julius Nam, from Pacific Union College. 
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